Mylan (Switzerland)

Mylan (Switzerland)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mylan (Switzerland), Switzerland, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

57%


Total
Publications

2.5K


Total Open
Publications

1.4K


Total
Citations

109K


Open Access
Percentage

57%


Total
Publications

2.5K


Total Open
Publications

1.4K


Total
Citations

109K

Wikipedia

Website

download

Breakdown

16% 27% 13% 44%

Publisher Open

16%

Both

27%

Other Platform Open

13%

Closed

44%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

384

Hybrid 27%

286

No Guarantees 37%

397

Other Platform Open

Institution 82%

825

Domain 25%

249

Other Internet 14%

140

Preprint 5%

52

Public 3%

28

Other Platform Locations

Name

Platform Type

Publications

University of Milan
Institution
282
PubMed Central
Domain
246
doaj.org OAI-PMH Repository
Institution
158
University of Castilla-La Mancha
Institution
126
DOI
Other Internet
96
Istituto Nazionale di Fisica Nucleare, Sezione di Catania
Institution
77
University of Milano-Bicocca
Institution
76
Unknown Repository
Other Internet
74
Office of Scientific and Technical Information
Institution
43
arXiv
Preprint
32
1 / 18

Data updated 12 August 2026

Share

Share

Share